Published in Neurobiol Aging on January 13, 1987
Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat (2005) 3.02
Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol (1994) 2.23
Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol (2011) 1.91
Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol (2005) 1.61
Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol (1994) 1.26
Controlled inspiration depth reduces variance in breath-holding-induced BOLD signal. Neuroimage (2007) 1.19
Brain aging in the oldest-old. Curr Gerontol Geriatr Res (2010) 0.90
Exercise as an intervention for the age-related decline in neural metabolic support. Front Aging Neurosci (2010) 0.86
Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging. Age (Dordr) (2016) 0.78
Semi-automated rapid quantification of brain vessel density utilizing fluorescent microscopy. J Neurosci Methods (2016) 0.75
Age-related Impairment of Vascular Structure and Functions. Aging Dis (2017) 0.75
Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature (1990) 4.90
Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome. Ann Neurol (1995) 3.34
Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry (1990) 2.91
Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques. Neuron (1995) 2.90
The occurrence and significance of intracerebral micro-aneurysms. J Pathol Bacteriol (1967) 2.74
Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat Med (1996) 2.71
The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science (1988) 2.49
A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci (1987) 2.43
The neuropathology of Alzheimer's disease: a review with pathogenetic, aetiological and therapeutic considerations. Mech Ageing Dev (1985) 2.08
Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor. J Biol Chem (1989) 2.00
A prospective, population-based study of the demographics, epidemiology, management, and outcome of out-of-hospital pediatric cardiopulmonary arrest. Ann Emerg Med (1999) 1.96
Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol (1998) 1.93
Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry (1986) 1.83
Progressive language disorder due to lobar atrophy. Ann Neurol (1992) 1.82
A critical survey of techniques for arterial mensuration. J Pathol (1972) 1.80
Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases. Lancet (1994) 1.78
Changes in the monoamine containing neurones of the human CNS in senile dementia. Br J Psychiatry (1980) 1.74
Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest (1998) 1.70
Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am J Pathol (2000) 1.66
Disease-specific patterns of locus coeruleus cell loss. Ann Neurol (1992) 1.64
Tau, ubiquitin, and alpha B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch Neurol (1995) 1.59
Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J Biol Chem (1995) 1.56
Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry (1999) 1.55
Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes. Neuropathol Appl Neurobiol (1984) 1.47
Percutaneous pulmonary endoarterial biopsy in an experimental model of pulmonary hypertension. Chest (1998) 1.46
Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J Clin Invest (1997) 1.44
Polyploidy in the human nervous system. 1. The DNA content of neurones and glia of the cerebellum. J Neurol Sci (1973) 1.41
Lipoprotein pigments--their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells. Brain (1974) 1.37
Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. Am J Pathol (1996) 1.36
Alzheimer's disease: a correlative study. J Neurol Neurosurg Psychiatry (1986) 1.36
The clinical pathological correlates of lobar atrophy. Dementia (1993) 1.31
The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol (1999) 1.31
Polyploidy in the human nervous system. 2. Studies of the glial cell populations of the Purkinje cell layer of the human cerebellum. J Neurol Sci (1973) 1.31
Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age. J Neurol Sci (1985) 1.31
Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein. Exp Neurol (1999) 1.30
Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's disease. Neurosci Lett (1985) 1.22
The pathology of the human locus ceruleus. Clin Neuropathol (1983) 1.20
Classification and description of frontotemporal dementias. Ann N Y Acad Sci (2000) 1.19
Lipoprotein pigments--their relationship to ageing in the human nervous system. I. The lipofuscin content of nerve cells. Brain (1974) 1.19
The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropathol Appl Neurobiol (1988) 1.19
The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet (2000) 1.16
The relationship between lipofuscin pigment and ageing in the human nervous system. J Neurol Sci (1978) 1.16
A pathological study of the association between Lewy body disease and Alzheimer's disease. J Neurol Neurosurg Psychiatry (1989) 1.15
The noradrenergic system in Alzheimer and multi-infarct dementias. J Neurol Neurosurg Psychiatry (1982) 1.15
Early senile plaques in Down's syndrome brains show a close relationship with cell bodies of neurons. Neuropathol Appl Neurobiol (1990) 1.15
A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1984) 1.15
The selective vulnerability of nerve cells in Huntington's disease. Neuropathol Appl Neurobiol (2001) 1.14
Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology (2002) 1.14
Familial progressive aphasia: its relationship to other forms of lobar atrophy. J Neurol Neurosurg Psychiatry (1993) 1.12
Cytophotometric mapping of neuronal changes in senile dementia. J Neurol Neurosurg Psychiatry (1977) 1.11
Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment. Mech Ageing Dev (1984) 1.11
Diurnal variations in human corneal thickness. Br J Ophthalmol (1996) 1.10
Pathological basis for neurotransmitter changes in Parkinson's disease. Neuropathol Appl Neurobiol (1983) 1.10
An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging (1987) 1.10
Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J Neurochem (1987) 1.09
The topography of plaques and tangles in Down's syndrome patients of different ages. Neuropathol Appl Neurobiol (1987) 1.09
Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect Immun (1999) 1.09
Neuromelanin and RNA in cells of substantia nigra. J Neuropathol Exp Neurol (1977) 1.08
Consequences of Hox gene duplication in the vertebrates: an investigation of the zebrafish Hox paralogue group 1 genes. Development (2001) 1.07
The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system. Mech Ageing Dev (1983) 1.06
Corneal donor infection by herpes simplex virus: herpes simplex virus DNA in donor corneas. Cornea (1994) 1.03
Detection of herpes simplex virus DNA in donor cornea culture medium by polymerase chain reaction. Br J Ophthalmol (1996) 1.03
A quantitative analysis of the incorporation of fibulin-1 into extracellular matrix indicates that fibronectin assembly is required. Matrix Biol (1995) 1.02
Loss of nerve cells from locus coeruleus in Alzheimer's disease is topographically arranged. Neurosci Lett (1986) 1.02
Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Arch Neurol (1995) 1.02
The topography of cell loss from locus caeruleus in Alzheimer's disease. J Neurol Sci (1986) 1.02
The effect of age and Alzheimer's disease on pyramidal neuron density in the individual fields of the hippocampal formation. Acta Neuropathol (1992) 1.00
Cognitive change in motor neurone disease/amyotrophic lateral sclerosis (MND/ALS). J Neurol Sci (2000) 1.00
Fatal mercury intoxication in a dental surgery assistant. Br Dent J (1969) 0.99